Quarterly Transactions Made in Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA). The information is specifically focused on institutions that hold shares of ENANTA PHARMACEUTICALS INC.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,588,560 | 746,451 | 2,335,011 | 1,107,529 | 243,782 | 1,351,311 | 983,700 | |
| Q4 2021 | 951,397 | 920,230 | 1,871,627 | 2,271,884 | 117,649 | 2,389,533 | -517,906 | |
| Q1 2022 | 1,087,276 | 1,528,783 | 2,616,059 | 1,445,696 | 637,223 | 2,082,919 | 533,140 | |
| Q2 2022 | 2,321,899 | 471,831 | 2,793,730 | 1,373,544 | 553,698 | 1,927,242 | 866,488 | |
| Q3 2022 | 667,303 | 482,243 | 1,149,546 | 1,069,662 | 17,531 | 1,087,193 | 62,353 | |
| Q4 2022 | 1,281,458 | 886,284 | 2,167,742 | 706,875 | 0 | 706,875 | 1,460,867 | |
| Q1 2023 | 1,906,155 | 473,314 | 2,379,469 | 1,033,159 | 509 | 1,033,668 | 1,345,801 | |
| Q2 2023 | 2,013,867 | 322,478 | 2,336,345 | 741,507 | 157,472 | 898,979 | 1,437,366 | |
| Q3 2023 | 3,038,072 | 3,045,012 | 6,083,084 | 3,875,740 | 159,826 | 4,035,566 | 2,047,518 | |
| Q4 2023 | 2,851,044 | 2,834,738 | 5,685,782 | 1,169,915 | 0 | 1,169,915 | 4,515,867 | |
| Q1 2024 | 3,597,186 | 2,169,235 | 5,766,421 | 2,348,368 | 0 | 2,348,368 | 3,418,053 | |
| Q2 2024 | 1,062,831 | 136,831 | 1,199,662 | 2,104,735 | 0 | 2,104,735 | -905,073 | |
| Q3 2024 | 1,433,982 | 352,833 | 1,786,815 | 1,775,473 | 0 | 1,775,473 | 11,342 | |